Table 1

Baseline characteristics

VariableHyperhomocysteinemic group; n = 360
Normohomocysteinemic group; n = 341
Multivitamin; n = 177Placebo; n = 183Multivitamin; n = 176Placebo; n = 165
Sex, M/F (%) 103/74 (58/42) 105/78 (57/43) 80/96 (45/55) 74/91 (45/55) 
Median age, y (range) 56.4 (18.1-79.9) 57.2 (17.9-79.8) 48.2 (20.2-75.5) 46.3 (19.1-78.5) 
Type of first event, no. (%)     
    DVT 119 (67) 126 (69) 97 (55) 100 (61) 
    PE 43 (24) 40 (22) 60 (34) 51 (31) 
    Both 15 (8) 17 (9) 19 (11) 14 (8) 
Median duration of anticoagulation after randomization, mo (range) 1.6 (0-30) 1.8 (0-30) 1.5 (0-18) 1.6 (0-30) 
Geometric mean baseline homocysteine level, μM 15.1 15.9 9.0 9.0 
    95% CI 14.3-16.0 14.9-17.0 8.7-9.3 8.7-9.3 
    Range 6.3-84.8 7.4-108.3 4.0-23.0 4.0-15.5 
Geometric mean homocysteine level after 3 mo, μM 8.5 15.6 6.5 9.7 
    95% CI 8.1-8.9 14.5-16.8 6.2-6.7 9.4-10.1 
    Range 4.1-21.3 6.0-91.7 2.9-11.6 5.4-25.6 
VariableHyperhomocysteinemic group; n = 360
Normohomocysteinemic group; n = 341
Multivitamin; n = 177Placebo; n = 183Multivitamin; n = 176Placebo; n = 165
Sex, M/F (%) 103/74 (58/42) 105/78 (57/43) 80/96 (45/55) 74/91 (45/55) 
Median age, y (range) 56.4 (18.1-79.9) 57.2 (17.9-79.8) 48.2 (20.2-75.5) 46.3 (19.1-78.5) 
Type of first event, no. (%)     
    DVT 119 (67) 126 (69) 97 (55) 100 (61) 
    PE 43 (24) 40 (22) 60 (34) 51 (31) 
    Both 15 (8) 17 (9) 19 (11) 14 (8) 
Median duration of anticoagulation after randomization, mo (range) 1.6 (0-30) 1.8 (0-30) 1.5 (0-18) 1.6 (0-30) 
Geometric mean baseline homocysteine level, μM 15.1 15.9 9.0 9.0 
    95% CI 14.3-16.0 14.9-17.0 8.7-9.3 8.7-9.3 
    Range 6.3-84.8 7.4-108.3 4.0-23.0 4.0-15.5 
Geometric mean homocysteine level after 3 mo, μM 8.5 15.6 6.5 9.7 
    95% CI 8.1-8.9 14.5-16.8 6.2-6.7 9.4-10.1 
    Range 4.1-21.3 6.0-91.7 2.9-11.6 5.4-25.6 

or Create an Account

Close Modal
Close Modal